-
Novo Nordisk CFO: U.S. Obesity Market Must Emerge, But It Will Take Time
Thursday, April 30, 2015 - 1:57pm | 395Novo Nordisk A/S (ADR) (NYSE: NVO) came out with better-than-expected quarterly results earlier on Thursday. Revenue for the company was up by 24 percent year-over-year to DKK 25.2 billion kroner, while net profit increased from DKK 6.46 billion to DKK 9.88 billion (DKK = Danish krone). Novo...